Home › Attention Deficit Hyperactivity Disorder › Florida › Jacksonville
Attention Deficit Hyperactivity Disorder clinical trials in Jacksonville, FL
5 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Jacksonville
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Jacksonville
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
RecruitingPhase 3
- CNS Healthcare - Jacksonville (Clinical Neuroscience Solutions - Jacksonville), Jacksonville
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
RecruitingPhase 2
- Alkermes Investigational Site, Jacksonville
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Clinical Neuroscience Solutions, Inc., Jacksonville
About Attention Deficit Hyperactivity Disorder
Attention deficit hyperactive disorder (ADHD) is a neurodevelopmental disorder. Its main symptoms are inattention, hyperactivity, and impulsivity. Learn more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX7 studies
- Philadelphia, PA6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA5 studies
- Portland, OR5 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Baltimore, MD4 studies
- Los Angeles, CA4 studies
Other studies in Jacksonville
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)29 studies
- Metastatic Cancer27 studies
- Colorectal Cancer25 studies
- Prostate Cancer25 studies
- Obesity25 studies
- Pancreatic Cancer21 studies
- Heart Failure20 studies
- Overweight19 studies
- Multiple Myeloma19 studies
- Lung Cancer18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.